Company: DHR
Filing Date: 2025-03-26
Form Type: DEF 14A
Source: 0000313616-25-000081
Chunk: 7

Company: DANAHER CORP /DE/
Filing Date: 2025-03-26
Form: DEF 14A
Chunk 7
---
 in our overall strategy as well as the breadth of our portfolio, it is important that our Board include members with the experience of having led the Company through a range of M&A and economic cycles. At the same time, our Board seeks to thoughtfully balance the knowledge and experience that comes from longer-term Danaher Board service with the fresh perspectives and additional expertise that can come from new directors.

◦ The Board does not have a formal or informal policy with respect to diversity but believes that the Board, taken as a whole, should embody a diverse set of skills, knowledge, experiences and backgrounds appropriate in light of the Company’s needs.

• Director capacity and availability . Our Board believes all Danaher directors must be willing and able to devote the substantial time required to carry out their duties and responsibilities as Board members. Please see “Director Capacity and Availability” below for details regarding implementation of this expectation.

• Refreshment . Board refreshment has been a natural outcome of the evolution described above. We have added five new directors over the past six years, which along with director retirements have reduced Danaher's average director nominee tenure by more than 18% over that period.

### Director Nominee Skills, Expertise and Background
The chart that follows illustrates the diverse set of skills, expertise and backgrounds represented by the Company's 2025 director nominees.

| Skills and Expertise |     |                                     |     | Blair |     | Dewan |     | Filler |     | Lamanna |     | List |     | Mega |     |    M. 
 Rales |     |    S. 
 Rales |     | Sanders |     | Schwieters |     | Spoon |     | Stevens |     | Zerhouni |     | TOTAL |
|                      |     | Global/International                |     |     l |     |     l |     |      l |     |       l |     |    l |     |    l |     |     l |     |     l |     |       l |     |            |     |       |     |       l |     |        l |     |    11 |
|                      |     | Life Sciences                       |     |     l |     |       |     |        |     |         |     |      |     |    l |     |       |     |       |     |         |     |            |     |       |     |       l |     |        l |     |     4 |
|                      |